Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Allergy & Cold Medication Recalls

Recalls of antihistamines, decongestants and nasal sprays.

314 recalls in this category, newest first.

Class II · Moderate risk

J-TAN D PD Drops

Labeling: Not Elsewhere Classified: Product is labeled "Dye Free" on front panel but contains Red Dye 40.

Terminated Labeling / mix-up Jaymac Pharmaceuticals L.L.C. D-0327-2015
Class II · Moderate risk

Loratadine active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-769-2015
Class II · Moderate risk

Fluticasone Propionate active pharmaceutical ingredient packaged…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-690-2015
Class II · Moderate risk

Cetirizine HCI active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-573-2015
Class II · Moderate risk

Diphenhydramine

Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.

Terminated Chemical / undeclared Brookfield Prescription Center Inc. dba MD Custom Rx D-1417-2014
Class III · Low risk

Advil PM Caplets

Subpotent Drug: This lot is being recalled because of out-of-specification test results for Diphenhydramine citrate.

Terminated Wrong potency / content Pfizer Us Pharmaceutical Group NDC 0573-0164-43 D-1166-2014
Class III · Low risk

Cetirizine Hydrochloride Syrup

Failed impurities/degradation specifications; out of specification for the known impurity 4-chlorobenzophenone.

Terminated Impurity / degradation Qualitest Pharmaceuticals NDC 0603-9063-54 D-394-2014
Class III · Low risk

Loratadine 24 HR-OTC

Failed Tablet/Capsule Specifications: Affected lot numbers may contain chipped or broken tablets.

Terminated Failed specification Physicians Total Care, Inc. NDC 54868-5268-00 D-0239-2015
Class III · Low risk

Loratadine

Failed Tablet/Capsule Specifications: The products are being recalled due to chipped and broken tablets.

Terminated Failed specification Novartis Consumer Health D-022-2014
Class II · Moderate risk

Cetirizine HCL

Labeling: Label Mixup: CETIRIZINE HCL, Tablet, 5 mg may have potentially been mislabeled as the following drug: LITHIUM CARBONATE ER, Tablet, 300 mg, NDC 00054002125, Pedigree: AD39564_1, EXP: 5/13/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-906-2014
Class II · Moderate risk

LORATADINE Tablet

Labeling: Label Mixup; LORATADINE Tablet, 10 mg may be potentially mislabeled as GLYCOPYRROLATE, Tablet, 2 mg, NDC 00603318121, Pedigree: W002650, EXP: 6/5/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 05445800022, Pedigree: AD21858_4, EXP: 5/1/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: W003217, EXP: 6/14/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-570-2014
Class II · Moderate risk

FEXOFENADINE HCl Tablet

Labeling: Label Mixup; FEXOFENADINE HCL Tablet, 60 mg may be potentially mislabeled as PYRIDOXINE HCL, Tablet, 50 mg, NDC 51645090901, Pedigree: W003019, EXP: 6/12/2014; NIACIN TR, Capsule, 500 mg, NDC 00904063160, Pedigree: AD60240_17, EXP: 5/22/2014; CRANBERRY EXTRACT/VITAMIN C, Capsule, 450 mg/125 mg, NDC 31604014271, Pedigree: AD46257_13, EXP: 5/15/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-568-2014
Class II · Moderate risk

Fexofenadine HCL

Labeling: Label Mixup; FEXOFENADINE HCL Tablet, 180 mg may be potentially mislabeled as MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 00536406001, Pedigree: AD62992_8, EXP: 5/23/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-554-2014
Class II · Moderate risk

diphenhydrAMINE HCl

Labeling: Label Mixup; diphenhydrAMINE HCl, Tablet, 25 mg may be potentially mislabeled as ATORVASTATIN CALCIUM, Tablet, 40 mg, NDC 00378212177, Pedigree: AD33897_10, EXP: 5/9/2014; ATORVASTATIN CALCIUM, Tablet, 10 mg, NDC 00378201577, Pedigree: W002774, EXP: 6/6/2014; PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet, NDC 51991056601, Pedigree: W003511, EXP: 6/21/2014; VENLAFAXINE, Tablet, 25 mg

Terminated Labeling / mix-up Aidapak Services, LLC D-483-2014
Class II · Moderate risk

Pseudoephedrine HCL

Labeling: Label Mixup; PSEUDOEPHEDRINE HCL, Tablet, 60 mg may be potentially mislabeled as REPAGLINIDE, Tablet, 1 mg, NDC 00169008281, Pedigree: W002855, EXP: 6/7/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-475-2014
Class II · Moderate risk

Pseudoephedrine HCL

Labeling: Label Mixup; PSEUDOEPHEDRINE HCL, Tablet, 30 mg may be potentially mislabeled as D-ALPHA TOCOPHERYL ACETATE, Capsule, 400 units, NDC 49348041010, Pedigree: AD52993_28, EXP: 5/20/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-469-2014
Class II · Moderate risk

NeoCitran

Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.

Terminated Particulate / foreign matter Novartis Consumer Health D-758-2014